Gujarat Kidney And Super Speciality Ltd.

•

gujaratsuperspecialityhospital.comBSE: 544666NSE: GKSL

Market Cap₹ 1,347 Cr.

Current Price

High / Low₹ 181 / 98

Stock P/E85.0

Book Value₹ 33

Price to Book5.23

Dividend Yield0.00 %

ROCE63.0 %

ROE68.6 %

Face Value₹ 2

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence

50%

View full sector analysis →

PROS

Company has a good return on equity (ROE) track record: 3 Years ROE 76.5%
Company has a healthy return on capital (ROCE) of 32.3%
Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.32x)
Working capital cycle has improved - days down from 190 to 1
Company comfortably covers its interest (20.8x coverage)
Company generates healthy free cash flow

CONS

Total debt has risen sharply - up 99.6% year on year

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcareHospital & Healthcare Services

Part ofNIFTY 50 NIFTY 500 NIFTY LARGEMIDCAP 250 NIFTY 100 NIFTY 200

S.No.	Name
1.	APOLLOHOSP	8850.00	60.90	127249.42	0.23	610.40	38.41	7043.50	20.56	21.73	15.70
2.	MAXHEALTH	1037.20	69.29	100951.74	0.19	322.96	4.87	2366.17	16.70	14.97	25.29
3.	MANIPALHOS	716.15	105.57	94200.74	0.00	2434.30	—	30906.30	—	13.93	23.83
4.	FORTIS	887.30	63.93	66987.44	0.11	272.80	2.26	2545.03	17.46	14.07	21.28
5.	ASTERDM	762.95	208.69	66504.25	0.39	29.28	-68.70	1310.68	21.60	11.26	19.53
6.	MEDANTA	1447.55	69.98	38920.53	0.03	157.25	-1.09	1304.05	26.50	19.38	21.99
7.	NH	1867.35	46.76	38161.31	0.24	207.27	5.37	2683.63	78.05	16.20	17.43
8.	KIMS	768.85	158.06	32292.20	0.00	37.40	-56.00	1179.50	35.33	11.51	19.03
9.	LALPATHLAB	1909.40	59.14	32049.05	1.07	1705.00	1172.39	7977.00	1090.95	29.56	31.03
10.	AGARWALEYE	507.00	108.33	16073.23	0.00	55.02	44.56	614.02	25.97	16.14	27.75
11.	VIJAYA	1502.30	82.53	15473.35	0.13	53.10	37.61	230.98	22.83	30.28	42.66
12.	GKSL	170.80	85.04	1346.64	0.00	53.21	884.82	342.89	2146.99	63.02	24.43

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	9	12	10	15	13	23	31	34
	5	7	7	8	8	16	24	28
Operating Profit	5	5	3	7	5	7	6	6
OPM %	51.65%	38.93%	26.69%	49.02%	39.60%	29.68%	20.60%	18.30%
	0	0	0	0	0	0	1	1
Interest	0	0	0	0	0	1	1	1
Depreciation	1	1	1	1	1	1	2	1
Profit before Tax	4	4	2	7	4	5	5	7
Tax %	26.25%	29.72%	16.88%	27.85%	28.54%	26.24%	-2.99%	23.58%
Net Profit	0	0	0	5	3	4	5	5
	0.65	0.52	0.25	0.85	0.52	0.52	0.81	0.66

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
	0	0	5	40	101
	0	0	3	24	76
Operating Profit	-0	-0	2	17	25
OPM %	—	—	40.86%	41.12%	24.34%
	1	0	1	0	2
Interest	0	0	0	1	2
Depreciation	1	0	0	3	5
Profit before Tax	0	-0	2	13	21
Tax %	26.85%	-0.00%	24.44%	25.58%	19.18%
Net Profit	0	-0	2	9	17
EPS	0.03	-0.06	85.70	1.66	—
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	—

COMPOUNDED SALES GROWTH

10 Years:: —
5 Years:: —
3 Years:: —

COMPOUNDED PROFIT GROWTH

10 Years:: —
5 Years:: —
3 Years:: 355%

STOCK PRICE CAGR

10 Years:: —
5 Years:: —
3 Years:: —
1 Year:: —

RETURN ON EQUITY

10 Years:: —
5 Years:: —
3 Years:: 76%
Last Year:: 69%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	0	0	0	11
Minority Interest	0	0	0	1
	0	0	2	15
	0	0	5	7
Trade Payables	3	3	2	3
	-0	-0	11	17
Total Liabilities	4	4	20	55
	3	0	14	31
	0	0	0	1
	0	0	4	15
Cash & Bank	0	0	1	3
	1	4	1	5
Total Assets	4	4	20	55

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2024	Mar 2025
	1	14
Cash from Investing	0	-18
Cash from Financing	-0	6
	1	2

Ratios

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2022	Mar 2023	Mar 2024	Mar 2025

Shareholding Pattern

Numbers in percentages

	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	71.45	71.45	71.45	71.45
	13.09	10.47	4.89	4.89
	2.85	1.67	0.56	0.56
Government	0.00	0.00	0.00	0.00
	12.61	16.40	23.10	23.11

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-04

Copy of Newspaper Publication

2026-09-04 - Gujarat Kidney And Super Speciality Limited has informed the Exchange about Copy of Newspaper Publication about mailing Annual report

2026-09-03

Shareholders meeting

2026-09-03 - Gujarat Kidney And Super Speciality Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 28, 2026

2026-09-01

General Updates

2026-09-01 - Gujarat Kidney And Super Speciality Limited has informed the Exchange about Pre advertisement for Notice of 7th AGM

2026-08-27

Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-27 - Gujarat Kidney And Super Speciality Limited has informed the Exchange about Schedule of meet

2026-08-24

Outcome of Board Meeting

2026-08-24 - Gujarat Kidney And Super Speciality Limited has informed the Exchange regarding Outcome of Board Meeting held on August 24, 2026.

2026-08-24

Updates

2026-08-24 - Gujarat Kidney And Super Speciality Limited has informed the Exchange regarding 'Outcome of Board Meeting' - Appointment of Additional Director subject to confirmation by shareholders at the ensuing Annual General Meeting and taking note of resolution passed by Postal ballot

2026-08-24

Appointment

2026-08-24 - Gujarat Kidney And Super Speciality Limited has informed the Exchange regarding Appointment of Mrs Disha Bharpoda as Non- Executive Independent Director of the company w.e.f. August 24, 2026.

2026-08-14

Updates

2026-08-14 - Gujarat Kidney And Super Speciality Limited has informed the Exchange regarding 'Financial results for Quarter ended June 2026'.

2026-08-14

Outcome of Board Meeting

2026-08-14 - Gujarat Kidney And Super Speciality Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

News

Recent coverage and analyst commentary for GKSL

Loading news…

🤖

AI Stock Analyst

Gujarat Kidney And Super Speciality Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account

Name

APOLLOHOSP

8850.00

60.90

127249.42

0.23

610.40

38.41

7043.50

20.56

21.73

15.70

MAXHEALTH

1037.20

69.29

100951.74

0.19

322.96

4.87

2366.17

16.70

14.97

25.29

MANIPALHOS

716.15

105.57

94200.74

0.00

2434.30

—

30906.30

—

13.93

23.83

FORTIS

887.30

63.93

66987.44

0.11

272.80

2.26

2545.03

17.46

14.07

21.28

ASTERDM

762.95

208.69

66504.25

0.39

29.28

-68.70

1310.68

21.60

11.26

19.53

MEDANTA

1447.55

69.98

38920.53

0.03

157.25

-1.09

1304.05

26.50

19.38

21.99

1867.35

46.76

38161.31

0.24

207.27

5.37

2683.63

78.05

16.20

17.43

KIMS

768.85

158.06

32292.20

0.00

37.40

-56.00

1179.50

35.33

11.51

19.03

LALPATHLAB

1909.40

59.14

32049.05

1.07

1705.00

1172.39

7977.00

1090.95

29.56

31.03

AGARWALEYE

507.00

108.33

16073.23

0.00

55.02

44.56

614.02

25.97

16.14

27.75

VIJAYA

1502.30

82.53

15473.35

0.13

53.10

37.61

230.98

22.83

30.28

42.66

GKSL

170.80

85.04

1346.64

0.00

53.21

884.82

342.89

2146.99

63.02

24.43

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

Operating Profit

OPM %

51.65%

38.93%

26.69%

49.02%

39.60%

29.68%

20.60%

18.30%

Interest

Depreciation

Profit before Tax

Tax %

26.25%

29.72%

16.88%

27.85%

28.54%

26.24%

-2.99%

23.58%

Net Profit

0.65

0.52

0.25

0.85

0.52

0.81

0.66

Mar 2022

Mar 2023

Mar 2024

Mar 2025

TTM

101

Operating Profit

-0

OPM %

—

40.86%

41.12%

24.34%

Interest

Depreciation

Profit before Tax

-0

Tax %

26.85%

-0.00%

24.44%

25.58%

19.18%

Net Profit

-0

EPS

0.03

-0.06

85.70

1.66

—

Dividend Payout %

0.00%

—

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Equity Capital

Minority Interest

Trade Payables

-0

Total Liabilities

Cash & Bank

Total Assets

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Cash from Investing

-18

Cash from Financing

-0

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

71.45

13.09

10.47

4.89

2.85

1.67

0.56

Government

0.00

12.61

16.40

23.10

23.11

Gujarat Kidney And Super Speciality Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI

Gujarat Kidney And Super Speciality Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI